| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/13/2011 | US20110008449 Human Specific Escherichia Coli Strains |
| 01/13/2011 | US20110008414 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines |
| 01/13/2011 | US20110008389 Recombinant attenuated clostridium organisms and vaccine |
| 01/13/2011 | US20110008380 Anaplasma Phagocytophilum (Aph) Antigens and Antibodies Specific for Anaplasma |
| 01/13/2011 | US20110008376 Immunogenic compositions capable of activating t-cells |
| 01/13/2011 | US20110008370 Novel use of flj25416 gene |
| 01/13/2011 | US20110008358 Human monoclonal antibodies that specifically bind igf-ii |
| 01/13/2011 | US20110008353 Identification of astrovirus va1 associated with gastroenteritis in humans |
| 01/13/2011 | US20110008347 Cancer-related protein kinases |
| 01/13/2011 | US20110008346 Biomarkers for cardiovascular disease |
| 01/13/2011 | US20110008339 Monoclonal antibody and use thereof |
| 01/13/2011 | US20110008335 Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using NK Cell Potentiating Compounds |
| 01/13/2011 | US20110008333 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 01/13/2011 | US20110008322 Anti-c35 antibody combination therapies and methods |
| 01/13/2011 | US20110008320 Further Use of Protein Kinase N Beta |
| 01/13/2011 | US20110008311 Animal Model and Use of 17Beta-Hydroxysteroid Dehydrogenase Type 7 in the Diagnosis of Anencephaly |
| 01/13/2011 | US20110008302 Compositions and methods for immortalizing cells and screening for anti-cancer agents |
| 01/13/2011 | US20110008292 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 01/13/2011 | US20110008290 Method for predicting the therapeutic responsiveness of patients to a medical treatment with an interferon |
| 01/13/2011 | US20110008278 Modulators of paraptosis and related methods |
| 01/13/2011 | US20110008273 Methods of skin whitening and of screening skin-spot-formation inhibiting and/or skin-spot removing factor |
| 01/13/2011 | US20110008259 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/13/2011 | US20110008258 Methods relating to breathing disorders |
| 01/13/2011 | US20110008249 Proteins with high immunoreactivity and method for their production |
| 01/13/2011 | US20110008211 Microfluid channel, method for its implementation, and microfluidic system containing said channel |
| 01/13/2011 | US20110006904 Managing a set of swimming pools |
| 01/13/2011 | US20110005302 Device and method to sample and enrich impurities in hydrogen |
| 01/13/2011 | DE112008003610T5 Pass-Fail-Tool, um den Verschmutzungsgrad durch Partikel in einem Fluid zu testen To test pass-fail tool the degree of contamination by particles in a fluid |
| 01/13/2011 | DE112008003471T5 Probenidentifizierung-Vorrichtung und Probenidentifizierungs-Verfahren Sample identification device and sample identification method |
| 01/13/2011 | DE102010006161B3 Determining gender of fertilized and non-incubated bird eggs, where egg has yolk surrounded by egg shell and embryonic disk arranged to yolk, by guiding probe into egg shell through hole in direction to the disk with embryonic disk cells |
| 01/13/2011 | DE102009032721A1 Gasmesssystem Gas Detection System |
| 01/13/2011 | DE102009032428A1 Anordnung, Substrat und Verfahren für eine Präparation einer Zellprobe Arrangement, substrate and method for preparing a cell sample |
| 01/13/2011 | DE102009032418A1 Individual prognosis of occurrence or progression of and/or for individual diagnosis of neuropathy of mammal, comprises detecting expression of mRNA of a gene in a tissue- or fluid sample of mammal, where the gene is e.g. adiponectin |
| 01/13/2011 | DE102009031733A1 Method for risk stratification of cancer patients identified with cancer disease, involves determining risk of potential of blood samples subjected to fluorescence study |
| 01/13/2011 | DE102009027599A1 Messgerät zur Abgasmessung Instrument for measuring exhaust gas |
| 01/13/2011 | CA2833576A1 Sampling and evaluation of subterranean formation fluid |
| 01/13/2011 | CA2767623A1 Compositions and methods for mammalian genetics and uses thereof |
| 01/13/2011 | CA2767605A1 Sample imaging system and method for transmitting an image of cells or tissues located in a culturing space to data processing means |
| 01/13/2011 | CA2767532A1 Bacterial adherence and anti-adherence to mucus and epithelial cells |
| 01/13/2011 | CA2767458A1 Biomarker for selecting patients and related methods |
| 01/13/2011 | CA2767167A1 Purification of monoclonal antibodies |
| 01/13/2011 | CA2767148A1 Process for the identification of compounds for treating cancer |
| 01/13/2011 | CA2766856A1 Detection and visualization of the cell cycle in living cells |
| 01/13/2011 | CA2765857A1 Method for generating aptamers with improved off-rates |
| 01/13/2011 | CA2765457A1 Methods for early detection of blood disorders |
| 01/13/2011 | CA2764937A1 Methods for analyzing polar metabolites of the energy metabolism |
| 01/13/2011 | CA2709605A1 Sampling and evaluation of subterranean formation fluid |
| 01/12/2011 | EP2273467A2 Gas generator or heat generator, smoke generator and method for checking a gas detector or a heat detector |
| 01/12/2011 | EP2273419A1 Methods of treating and preventing colitis involving IL-13 and NK-T cells |
| 01/12/2011 | EP2273273A1 Inhibitors of the nitration of amyloid ß peptides and their uses in the diagnosis and treatment of alzheimer's disease |
| 01/12/2011 | EP2273272A1 Method for predicting the outcome of chemotherapy in ovarian cancer |
| 01/12/2011 | EP2273271A2 Use of novel biomarkers for detection of testicular carcinoma in situ and derived cancers in human samples |
| 01/12/2011 | EP2273270A1 Method and apparatus for the preparation and/or analysis of biochemical carriers |
| 01/12/2011 | EP2273269A1 Biosensor manufacturing method and biosensor |
| 01/12/2011 | EP2273268A2 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 01/12/2011 | EP2273267A1 Methods or analyzing polar metabolites of the engergy metabolism |
| 01/12/2011 | EP2273266A1 Parasporin-1 receptor and use thereof |
| 01/12/2011 | EP2273265A1 Method for the diagnosis of asthma by detecting volatile organic compounds in exhaled air. |
| 01/12/2011 | EP2273264A1 Platelet measurement reagent, platelet measurement reagent kit, and platelet measurement method |
| 01/12/2011 | EP2273263A2 Method for electrically detecting physiologically active materials and biochip for the same |
| 01/12/2011 | EP2273262A2 Highly sensitive bio-sensor, biochip including same and method for manufacturing same |
| 01/12/2011 | EP2273261A1 Sensor device on a flexible carrier |
| 01/12/2011 | EP2273255A1 Device and method for determining the concentration of a substance |
| 01/12/2011 | EP2273251A2 Autonomous and remote-controlled multi-parametric buoy for multi-depth water sampling, monitoring, data collection, transmission, and analysis |
| 01/12/2011 | EP2273039A1 Water quality control in residential swinming pool |
| 01/12/2011 | EP2272988A2 Method for detecting human papillomavirus mRNA |
| 01/12/2011 | EP2272975A1 Method for determination of dna methylation |
| 01/12/2011 | EP2272961A1 Process for producing recombinant albumin with reduced mannosylation |
| 01/12/2011 | EP2272957A2 Bitter taste receptors |
| 01/12/2011 | EP2272955A1 Tdp-43-storing cell model |
| 01/12/2011 | EP2272953A1 Corynebacterium glutamicum gene encoding phosphoenolpyruvate-protein phosphotransferase |
| 01/12/2011 | EP2272951A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
| 01/12/2011 | EP2272948A1 Method for isolation of smooth muscle stem cell |
| 01/12/2011 | EP2272946A2 Minicell compositions and methods |
| 01/12/2011 | EP2272874A1 Role of PLD1 in thrombus formation and integrin alpha IIb beta 3 activation |
| 01/12/2011 | EP2272872A1 Monoclonal antibody specifically recognizing human interferon alpha subtype alpha-8 and mutant protein thereof |
| 01/12/2011 | EP2272869A2 Angiopoietin-2 specific binding agents |
| 01/12/2011 | EP2272864A2 Binding agents which inhibit myostatin |
| 01/12/2011 | EP2272860A1 Multivalent epitope in complex with a detection marker for the early serodiagnosis of infections |
| 01/12/2011 | EP2272840A1 Intermediate compound for the preparation of halichondrin analogs |
| 01/12/2011 | EP2272839A1 Intermediate compounds for the preparation of halichondrin analogs |
| 01/12/2011 | EP2272539A2 Truncated fragments of alpha-synuclein in lewy body disease |
| 01/12/2011 | EP2272514A1 Use of low dose pipamperone and a second active compound in the treatment of neurodegenerative diseases |
| 01/12/2011 | EP2272497A2 Methods Of Increasing Lymphatic Function |
| 01/12/2011 | EP2271943A1 Methods of monitoring the modulation of the kinase activity of fibroblast growth factor receptor and uses of said methods |
| 01/12/2011 | EP2271942A2 Biomarkers and assays for diabetes |
| 01/12/2011 | EP2271941A2 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
| 01/12/2011 | EP2271940A1 Detection of head and neck cancer using hypermethylated gene detection |
| 01/12/2011 | EP2271939A1 Sensitive immunoassays using coated nanoparticles |
| 01/12/2011 | EP2271938A1 Method and apparatus for nanoparticle electrogenerated chemiluminescence amplification |
| 01/12/2011 | EP2271937A1 Method and apparatus for detecting and counting platelets individually and in aggregate clumps |
| 01/12/2011 | EP2271936A1 In vitro method to determine whether a drug candidate active against a target protein is active against a variant of said protein |
| 01/12/2011 | EP2271935A1 Method and kit for the ex vivo evaluation of the response of a tumor to conditions to be tested |
| 01/12/2011 | EP2271934A1 Diagnosis and/or prognosis of renal dysfunction |
| 01/12/2011 | EP2271933A2 A system and method for cell characterisation |
| 01/12/2011 | EP2271932A2 Apparatus and methods for performing photoreactions and analytical methods and devices to detect photo-reacting compounds |
| 01/12/2011 | EP2271931A2 Microrna biomarkers of tissue injury |
| 01/12/2011 | EP2271930A1 Use of a steroid profile in ovarian follicular fluid for diagnosis, prognosis and determining strategies for treatment |
| 01/12/2011 | EP2271929A1 Use of nitrated lipids for treatment of lipid disorders and obesity, and lipid- and obesity-related conditions |
| 01/12/2011 | EP2271776A1 Antiviral therapy |